Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

36 results
  1. ... Training and home infusions for those with severe hemophilia B. Prevention of primary manifestations: For those with severe disease, ... seen in 1%-3% of persons with severe hemophilia B, greatly compromise the ability to manage ... of Primary Manifestations Prophylactic treatment is recommended by ...
  2. ... lack or decrease of clotting factor VIII (8) Hemophilia B (Christmas disease), which is caused by a lack ... treatment center (HTC). Centers for Disease Control and Prevention
  3. ... hemophilia B (also known as Christmas disease or factor IX deficiency). Although the two types have very similar signs ... different genes. People with an unusual form of hemophilia B, known as hemophilia B Leyden, experience episodes of ...
  4. ... also-called >Christmas disease</also-called><also-called >Factor IX deficiency</also-called><also-called >Factor VIII deficiency</also- ... decrease of clotting factor VIII (8)</li> <li>Hemophilia B (Christmas disease), which is caused by a lack ...
  5. ... Hemost. 2007 Jan; 13(1):14-34. Review Hemophilia B [GeneReviews ® . 1993] Review Hemophilia B Konkle BA, Huston H, Nakaya Fletcher S. GeneReviews®. ...
  6. ... Huston H, Nakaya Fletcher S. GeneReviews®. 1993 Review Hemophilia B [GeneReviews ® . 1993] Review Hemophilia B Konkle BA, Huston H, Nakaya Fletcher S. GeneReviews®. ...
  7. ... Anemia Mehta PA, Tolar J. GeneReviews®. 1993 Review Hemophilia B [GeneReviews ® . 1993] Review Hemophilia B Konkle BA, Huston H, Nakaya Fletcher S. GeneReviews®. ...
  8. ... evidence: None assigned Risk-reducing surgeries for the prevention of gynecologic cancers in Lynch syndrome An effective ... of evidence: 3b Vaccines in the treatment or prevention of MSI-related CRC An alternative approach to ...
  9. ... the plasma and urine [ Bartlett et al 2013 ]. Prevention of Primary Manifestations Treatment with nitisinone (Orfadin ® ) should begin as soon as the diagnosis is confirmed. Prevention of Secondary Complications Because carnitine deficiency secondary to ...
  10. ... and children are at increased risk for DVT. Prevention of Primary Manifestations MPI-CDG ( CDG-Ib ), characterized ... two years post transplant [ Janssen et al 2014 ]. Prevention of Secondary Complications Because infants with CDG have ...
first · previous · 1 · 2 · 3 · 4 · next · last